Validation of an MRI-based prostate cancer prebiopsy Gleason score predictive nomogram.

Journal: Current urology
Published Date: Dec 6, 2021

Abstract

BACKGROUND: Gleason score grading is a cornerstone of risk stratification and management of patients with prostate cancer (PCa). In this work, we derive and validate a nomogram that uses prostate multiparametric magnetic resonance imaging (MP-MRI) and clinical patient characteristics to predict biopsy Gleason scores (bGS).

Authors

  • Adrianna Jiaying Lee
    University of Maryland, Baltimore, MD, USA.
  • Amelia Wnorowski
    University of Maryland, Baltimore, MD, USA.
  • Nancy Ye
    University of Maryland, Baltimore, MD, USA.
  • Linhan Xu
    University of Maryland, Baltimore, MD, USA.
  • Michael Naslund
    University of Maryland, Baltimore, MD, USA.
  • Bradford J Wood
    Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Maria J Merino
    Center for Interventional Oncology, National Cancer Institute & Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Baris Turkbey
    Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Peter L Choyke
    Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Peter A Pinto
    Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • M Minhaj Siddiqui
    University of Maryland, Baltimore, MD, USA.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals